Choi, Y. J., Byun, Y., Kang, J. S., Kim, H. S., Han, Y., Kim, H., . . . Jang, J. (2021). Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX. Gut Liver.
शिकागो स्टाइल उद्धरणChoi, Yoo Jin, et al. "Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine Versus FOLFIRINOX." Gut Liver 2021.
एमएलए उद्धरणChoi, Yoo Jin, et al. "Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine Versus FOLFIRINOX." Gut Liver 2021.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.